联系客服

603811 沪市 诚意药业


首页 公告 诚意药业:浙江诚意药业股份有限公司关于2024年第一季度主要经营数据的公告

诚意药业:浙江诚意药业股份有限公司关于2024年第一季度主要经营数据的公告

公告日期:2024-04-26

诚意药业:浙江诚意药业股份有限公司关于2024年第一季度主要经营数据的公告 PDF查看PDF原文

 证券代码:603811        证券简称:诚意药业        公告编号:2024-017

                  浙江诚意药业股份有限公司

              2024 年第一季度主要经营数据的公告

      本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,

  并对其内容的真实性、准确性和完整性承担法律责任。

    根据上海证券交易所发布的《上市公司行业信息披露指引第六号——医药制造》 的要求,现将浙江诚意药业股份有限公司(以下简称“公司”)2024 年第一季度主
 要经营数据披露如下:

    一、报告期内,公司主营业务分行业、分产品经营情况:

                                                                  单位:元 币种:人民币

                                  主营业务分行业情况

                                                        营业收入 营业成本  毛利率比上
  分行业        营业收入        营业成本    毛利率(%) 比上年增 比上年增 年增减(%)
                                                        减(%)  减(%)

 医药制造业      152,642,184.03    45,085,208.37    70.46      3.49    -12.07        5.23

                                  主营业务分产品情况

                                                        营业收入 营业成本  毛利率比上
  分产品        营业收入        营业成本    毛利率(%) 比上年增 比上年增 年增减(%)
                                                        减(%)  减(%)

  制剂          126,625,879.51    31,278,018.35    75.30    13.89      1.42        3.04

  原料药          23,363,590.69    10,304,881.64    55.89    -26.64    -36.36        6.74

中间体及其他        1,054,476.15      2,471,593.77    -134.39    -56.83    -34.75      -79.31

  食品              949,965.51        725,643.91    23.61    253.11  1053.81      -53.01

  中药              648,272.17        305,070.70    52.94    -62.98    -21.82      -24.78

  合计          152,642,184.03    45,085,208.37    70.46      3.49    -12.07        5.23

      二、报告期内,公司主营业务按治疗领域划分的经营情况:

                                                                单位:元 币种:人民币

                                                        营业收入 营业成本比    毛利率
  治疗领域      营业收入      营业成本    毛利率(%) 比上年增  上年增减      比上年
                                                        减(%)    (%)      增减(%)


安神补脑类药物    7,126,424.05    4,175,322.91      41.41    -56.32    -55.92        -0.53

 关节类药物      95,531,367.30    23,755,264.91      75.13    32.50      5.11        6.48

 抗病毒类药物      7,031,729.52    4,433,244.66      36.95      4.37    -17.84        17.04

 抗肿瘤类药物      3,479,752.37    1,062,734.93      69.46    -61.01    -64.33        2.84

 利尿类药物        4,816,980.26      529,451.54      89.01    -69.74    -46.92        -4.73

 维生素类药物      18,894,944.63    1,483,377.78      92.15    65.30    164.74        -2.95

  其他类        13,117,334.02    6,150,287.26      53.11    11.16      17.83        -2.65

  中间体          1,045,414.20    2,464,809.77    -135.77    -53.37    -31.44      -75.41

    食品            949,965.51      725,643.91      23.61    253.11    1053.81      -53.01

    中药            648,272.17      305,070.70      52.94    -62.98    -21.82      -24.78

    合计        152,642,184.03    45,085,208.37      70.46      3.49    -12.07        5.23

    三、报告期内,公司主营业务分地区经营情况:

                                                              单位:元 币种:人民币

                                  主营业务分地区情况

                                                        营业收入 营业成本 毛利率比上年

  分地区        营业收入        营业成本  毛利率(%) 比上年增 比上年增  增减(%)

                                                        减(%)  减(%)

  境内          150,562,513.11    44,407,461.83      70.51      7.31      -8.81        5.21

  境外            2,079,670.92      677,746.54      67.41    -71.06    -73.71        3.30

  合计          152,642,184.03    45,085,208.37      70.46      3.49    -12.07        5.23

  特此公告

                                                  浙江诚意药业股份有限公司董事会
                                                            2024 年 4 月 25 日

[点击查看PDF原文]